H.C. Wainwright Downgrades Timber Pharmaceuticals (TMBR) to Neutral
Tweet
Share
E-mailGet Alerts TMBR Hot Sheet
Price: $0.34 --0%
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju downgraded Timber Pharmaceuticals (NYSE: TMBR) from Buy to Neutral.
For an analyst ratings summary and ratings history on Timber Pharmaceuticals click here. For more ratings news on Timber Pharmaceuticals click here.
Shares of Timber Pharmaceuticals closed at $3.03 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Citizens Downgrades SoundThinking (SSTI) to Market Perform
- Wolfe Research Downgrades T-Mobile (TMUS) to Peerperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
